4PC Stock Chart & Stats
€0.16
-€0.01(-5.35%)
At close: 4:00 PM EDT
€0.16
-€0.01(-5.35%)
Day’s Range― - ―
52-Week Range€0.08 - €0.46
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€27.16M
Enterprise Value€35.07
Total Cash (Recent Filing)€6.43M
Total Debt (Recent Filing)€4.01M
Price to Earnings (P/E)―
Beta-0.66
Next Earnings
Nov 17, 2026EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding153,434,620
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)7.00
Price to Sales (P/S)12.31
P/FCF Ratio-3.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€0.96Price Target Upside498.93% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.04
Revenue Forecast (FY)€3.00M
Bulls Say, Bears Say
Bulls Say
FDA Approval And Early Commercial AdoptionFDA clearance removes a key regulatory barrier for the next-generation platform, while initial hospital placements provide real-world validation. Converting existing S-Series users and adding new sites could support a durable installed-base and recurring-revenue expansion.
Recurring Revenue Model Gaining TractionRevenue from consumables, leases, maintenance and warranty programs can increase as installed systems perform more procedures. Fully recurring quarterly revenue and sequential growth indicate improving monetization quality, although the base remains early.
Improving Cost Discipline And Operating EfficiencyLower operating expenses, losses and cash use show management is controlling the cost base while commercialization develops. Sustained discipline could extend financial flexibility and allow future sales and marketing investment to translate into operating leverage.
Bears Say
Persistent Losses And Cash ConsumptionThe company has not yet demonstrated a self-funding model: substantial losses continue to convert into cash burn, while debt-to-equity rose to about 1.0. Prolonged commercialization delays could require additional financing and reduce strategic flexibility.
Small Scale And Uneven CommercializationThe limited installed base and modest revenue leave results dependent on a small number of deployments and procedures. Recent TTM contraction also shows that the commercial ramp is not yet consistent, increasing execution risk against longer-term growth plans.
Hospital AI And IT Reviews May Delay AdoptionInstitution-specific review requirements add friction to purchasing and deployment, potentially lengthening sales cycles and delaying conversions from the existing funnel. Slower approvals can postpone recurring revenue growth and make near-term pipeline timing difficult to forecast.
Perimeter Medical Imaging AI News
4PC FAQ
What was Perimeter Medical Imaging AI’s price range in the past 12 months?
Perimeter Medical Imaging AI lowest stock price was €0.08 and its highest was €0.46 in the past 12 months.
What is Perimeter Medical Imaging AI’s market cap?
Perimeter Medical Imaging AI’s market cap is €27.16M.
When is Perimeter Medical Imaging AI’s upcoming earnings report date?
Perimeter Medical Imaging AI’s upcoming earnings report date is Nov 17, 2026 which is in 56 days.
How were Perimeter Medical Imaging AI’s earnings last quarter?
Perimeter Medical Imaging AI released its earnings results on Aug 20, 2026. The company reported -€0.017 earnings per share for the quarter.
Is Perimeter Medical Imaging AI overvalued?
According to Wall Street analysts Perimeter Medical Imaging AI’s price is currently Undervalued.
Does Perimeter Medical Imaging AI pay dividends?
Perimeter Medical Imaging AI does not currently pay dividends.
What is Perimeter Medical Imaging AI’s EPS estimate?
Perimeter Medical Imaging AI’s EPS estimate is -0.03.
How many shares outstanding does Perimeter Medical Imaging AI have?
Perimeter Medical Imaging AI has 153,434,620 shares outstanding.
What happened to Perimeter Medical Imaging AI’s price movement after its last earnings report?
Perimeter Medical Imaging AI reported an EPS of -€0.017 in its last earnings report. Following the earnings report the stock price went down -6.422%.
Which hedge fund is a major shareholder of Perimeter Medical Imaging AI?
Currently, no hedge funds are holding shares in DE:4PC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Perimeter Medical Imaging AI
Perimeter Medical Imaging AI, Inc. is a medical technology firm focused on developing and marketing advanced imaging solutions. These innovations empower surgeons, radiologists, and pathologists to meticulously examine microscopic tissue structures directly within a clinical setting. A cornerstone offering is their optical coherence tomography (OCT) imaging system, which delivers detailed cross-sectional views of tissues to a depth of 2 millimeters, comprising the S-series OCT, B-series OCT, and an associated imaging console. Complementing this, ImgAssist, an artificial intelligence platform, streamlines image analysis. When integrated with Perimeter's OCT technology, ImgAssist becomes a robust tool, providing physicians with real-time visualization and assessment of surgical margins. This capability significantly enhances patient surgical outcomes and diminishes the necessity for subsequent operations. The company further provides a specialized image library and disposable specimen containers, catering to hospitals and cancer treatment facilities. Established in 2013, Perimeter Medical Imaging AI, Inc. operates from its headquarters in Toronto, Canada.
4PC Stock 12 Month Forecast
Average Price Target
€0.96
▲(498.93% Upside)